In Vivo Preclinical Development and Animal Efficacy Studies
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract involves conducting in vivo preclinical development and animal efficacy studies focused on assessing the effectiveness, pharmacokinetics, and safety profiles of lead compounds targeting filovirus infections. This work is designed to evaluate how these compounds perform in animal models when challenged with filovirus, providing critical data to support further development of potential therapeutics. The contract is structured as a subcontract under the Department of Health and Human Services, specifically administered by the ASPR Administration for Strategic Preparedness and Response. The solicitation was posted on May 19, 2026, with a response deadline set for July 17, 2026. The contract falls under the NAICS code 541611, which corresponds to administrative management and general management consulting services. While details regarding location, organization type, and points of contact were not specified, the contract clearly focuses on advancing preclinical research aimed at addressing strategic health threats posed by filoviruses through thorough animal model testing.
General Info
Agency
NAICS
Place of Performance
DCSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
